STOCK TITAN

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A Form 4 Filings

BRKRP NASDAQ

Every Form 4 that Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow BRKRP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BRKRP filings page.

Rhea-AI Summary

BRUKER CORP (BRKR) reported equity compensation awards to officer Burkhard Prause. He received a grant of 3,303 shares of Common Stock in the form of Restricted Stock Units, which vest in equal installments on the first, second, third, and fourth anniversaries of the August 15, 2026 grant date. He was also granted Stock Options for 2,678 shares of Common Stock at an exercise price of $57.70 per share, vesting on the same four annual schedule and expiring on August 15, 2036. Following the Common Stock grant, his directly held Common Stock position is 28,461 shares.

Rhea-AI Summary

Bruker Corp (BRKR) reported insider equity transactions by Wolfgang Pusch, President BMID Group. On August 17, 2026, he sold 3,473 shares of Common Stock at $56.90 per share. On August 15, 2026, he received equity awards: 3,120 Restricted Stock Units that vest in four equal annual installments, and 2,529 stock options with a $57.70 exercise price, also vesting in four equal annual installments and expiring on August 15, 2036.

Rhea-AI Summary

BRUKER CORP (symbol: BRKR) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

BRUKER CORP (BRKR) reported that officer Juergen Srega, President CALID, received equity awards. He was granted 16,898 shares of common stock in the form of Restricted Stock Units, which vest in four equal annual installments starting on the first anniversary of the August 15, 2026 grant date, increasing his directly held common shares to 174,625. He was also granted a stock option for 13,698 shares of common stock at an exercise price of $57.70 per share, vesting in four equal annual installments from the same grant date, exercisable from August 15, 2027 until August 15, 2036.

Rhea-AI Summary

BRUKER CORP (BRKR) reported equity awards and related tax withholding for President & CEO Frank H. Laukien. On August 15, 2026, he received a grant of 71,651 stock options with an exercise price of $63.47 per share, vesting in four equal annual installments starting on the first anniversary of the grant date. He also received 29,463 Restricted Stock Units, which vest in four equal annual installments on the same schedule. On that date, 4,760 common shares were withheld at $57.70 per share to satisfy tax withholding obligations upon vesting of previously granted RSUs. Indirect holdings include 336,607 common shares held by a daughter.

Rhea-AI Summary

BRUKER CORP (BRKR) reported equity compensation transactions for Executive Vice President and CFO Gerald N. Herman on August 15, 2026. He received 15,794 shares of Common Stock as Restricted Stock Units that vest in four equal annual installments starting one year after the grant date, and a stock option for 12,803 shares of Common Stock at an exercise price of $63.47 per share, also vesting in four equal annual installments. The option expires on August 15, 2036. On the same date, 2,724 shares of Common Stock were withheld at $57.70 per share to satisfy tax withholding obligations upon vesting of previously granted restricted stock units.

Rhea-AI Summary

BRUKER CORP (BRKR) reported multiple equity compensation and trading transactions by executive vice president Mark Munch. On August 15, 2026, he received a grant of 11,708 stock options with an exercise price of $57.70 per share, vesting in four equal annual installments, and a grant of 14,443 Restricted Stock Units that also vest in four equal annual installments. That same day, 2,984 shares of common stock were withheld by the company to satisfy tax obligations upon vesting of previously granted RSUs. On August 14, 2026, he exercised 2,000 stock options at $22.19 per share, received 2,000 shares of common stock, and sold 2,000 shares at $57.60 per share pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Summary

BRUKER CORP executive Mark Munch, Executive Vice President and President of Bruker Nano Inc., reported a Form 4 transaction involving company common stock. On 2026-08-11, 1,619 shares of common stock were withheld by the company at $57.02 per share to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units. Following this tax-withholding disposition, Munch directly holds 123,347 shares of BRUKER CORP common stock.

Rhea-AI Summary

BRUKER CORP executive vice president and CFO Gerald N. Herman reported a Code F transaction involving 1,410 shares of common stock on 2026-08-11. According to the company’s disclosure, these shares were withheld to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units, rather than sold in an open-market transaction. Following this tax-withholding disposition, Herman’s directly held ownership stands at 98,284 shares of BRUKER CORP common stock.

Rhea-AI Summary

BRUKER CORP President & CEO Frank H. Laukien reported a Form 4 reflecting a code F transaction in the company’s common stock. On 2026-08-11, 4,838 shares were withheld by the company at $57.02 per share to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units. After this withholding, Laukien directly holds 38,482,340 common shares. The filing also lists various indirect holdings for family members, including 336,607 shares held indirectly “By Daughter.”

Rhea-AI Summary

BRUKER CORP executive Mark Munch, Executive VP and President of Bruker Nano Inc., reported two Form 4 transactions involving Common Stock coded "F". On 2026-08-10, 1,573 shares were withheld at $56.32 per share, and on 2026-08-09, 1,904 shares were withheld at $53.41 per share. According to the footnote, these 3,477 shares were withheld by the company to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units, rather than discretionary market sales.

Rhea-AI Summary

BRUKER CORP executive Gerald N. Herman, Executive Vice President and CFO, reported two transactions in company common stock. On August 9, 2026, and August 10, 2026, a total of 2,889 shares were withheld by the company at prices of $53.41 and $56.32 per share, respectively. According to the disclosure, these shares were withheld solely to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units, rather than representing open-market sales.

Rhea-AI Summary

BRUKER CORP President & CEO Frank H. Laukien reported two Form 4 transactions involving common stock used to cover taxes on equity compensation. On 2026-08-10, 4,564 shares were withheld at $56.32 per share, and on 2026-08-09, 2,361 shares were withheld at $53.41 per share. A footnote states these shares were withheld by the company to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units, rather than sold in open-market trades. The filing also lists several indirect ownership positions held through or for family members, including 336,607 shares held indirectly by a daughter after the reported date.

Rhea-AI Summary

Mark Munch, an executive vice president of Bruker Corp, exercised stock options for 2,000 shares at $22.19 per share and sold 2,000 common shares at $60.25 per share in open-market trades under a Rule 10b5-1 trading plan. After these transactions he holds 128,443 common shares directly and 4,000 stock options exercisable at $22.19 expiring on October 4, 2026.

Rhea-AI Summary

Bruker Corp executive Mark Munch reported an option exercise and related share sale. He exercised stock options to acquire 2,000 shares of Common Stock at $22.19 per share and on the same day sold 2,000 shares in an open‑market transaction at $54.76 per share.

The filing notes that the sales were made under a pre‑arranged Rule 10b5‑1 trading plan. Following these transactions, Munch directly holds 128,443 shares of Bruker Common Stock.

Rhea-AI Summary

Bruker Corp director Bernard Thierry reported an equity award of 2,886 shares of Common Stock in the form of Restricted Stock Units (RSUs). The RSUs were granted at no cash cost to him and represent stock-based compensation.

The RSUs will vest in one installment on May 15, 2027, and on that date each RSU will automatically convert into one share of Bruker Common Stock. Following this grant, Thierry holds 2,886 shares directly, reflecting this new award only and indicating a routine compensation-related acquisition rather than an open-market purchase.

Rhea-AI Summary

Bruker Corp executive Mark Munch exercised stock options and sold shares in a planned transaction. He exercised options for 2,000 shares of common stock at $22.19 per share and then sold 2,000 shares at $39.90 per share on the same date.

After these transactions, he directly owns 128,443 shares of Bruker common stock. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person.

Rhea-AI Summary

BRUKER CORP executive Mark Munch reported an option exercise and share sale. On March 13, he exercised stock options for 2,000 shares of common stock at $22.19 per share, then sold 2,000 shares of common stock at $35.44 per share.

Following these transactions, he directly held 128,443 shares of common stock. The filing notes that the sale was carried out under a pre-arranged Rule 10b5-1 trading plan, indicating a planned, routine liquidity event rather than an opportunistic trade.

Rhea-AI Summary

FRANCIS LAURA reported acquisition or exercise transactions in this Form 4 filing.

Bruker Corporation director Laura Francis received an equity award of 4,520 shares of Common Stock in the form of restricted stock units on February 15, 2026. The RSUs will vest in a single installment on February 15, 2027. After this grant, she holds 9,018 shares directly.

Rhea-AI Summary

Bruker Corp director Jack Phillips reported an equity award. On February 15, 2026, he acquired 4,520 shares of Common Stock through a grant classified as a “grant, award, or other acquisition.” The footnote explains this is represented by Restricted Stock Units that will vest in a single installment on February 15, 2027, when each unit will convert into one share of Common Stock. Following this award, his directly held position is reported as 4,520 shares.

Rhea-AI Summary

BRUKER CORP director John A. Ornell received an equity grant of 4,520 shares of Common Stock in the form of restricted stock units. The award was reported at no cash purchase price and increased his directly held stake to 39,732 shares after the transaction.

The RSUs will vest in a single installment on February 15, 2027. On that vesting date, each restricted stock unit will automatically convert into one share of Bruker common stock, aligning the director’s compensation with future company performance over the vesting period.

Rhea-AI Summary

BRUKER CORP director William A. Linton received an equity award of 4,520 restricted stock units (RSUs). The RSUs were granted at no cash cost and relate to the company’s common stock. After this grant, he directly holds 63,243 shares of common stock.

The footnote explains that these RSUs will vest in a single installment on February 15, 2027, and each RSU will automatically convert into one share of Bruker common stock at that time, aligning the director’s compensation more closely with future shareholder value.

Rhea-AI Summary

BRUKER CORP director Richard A. Packer received an equity award covering 4,520 shares of common stock as a grant of Restricted Stock Units. The RSUs will vest in a single installment on February 15, 2027, at which time each unit will convert into one share of common stock. After this award, Packer’s directly held common stock, including this grant, is reported at 93,694 shares. The grant was recorded at a price of $0.00 per share, consistent with a stock-based compensation award rather than an open-market purchase.

Rhea-AI Summary

Bruker Corp director Adelene Q. Perkins received an equity award of 4,520 restricted stock units (RSUs) of Common Stock on February 15, 2026. The RSUs will vest in a single installment on February 15, 2027, and each unit will convert into one share of Common Stock at vesting. After this grant, Perkins beneficially owns 29,144 shares of Common Stock directly.

Rhea-AI Summary

BRUKER CORP director Bob Rosenthal reported an equity award. He acquired 4,520 shares of Common Stock through a grant classified as a grant, award, or other acquisition at a stated price of $0.00 per share.

According to the footnote, this grant is in the form of Restricted Stock Units that will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into one share of Common Stock. After this award, Rosenthal directly holds 38,781 shares of Common Stock.

Rhea-AI Summary

BRUKER CORP director Cynthia M. Friend reported an equity award of 4,520 units tied to Common Stock. The award is structured as Restricted Stock Units (RSUs) that were granted at no cash cost on the transaction date. All 4,520 RSUs will vest in a single installment on February 15, 2027, and each RSU will automatically convert into one share of Common Stock at that time. Following this grant, she now directly holds 22,536 shares of Common Stock, reflecting her updated ownership position.

Rhea-AI Summary

BRUKER CORP Chief Accounting Officer Thomas Bures reported a tax-related share disposition. On the reported date, 274 shares of common stock were withheld at a price of $36.51 per share to satisfy tax withholding obligations tied to previously granted restricted stock units that vested. After this withholding transaction, Bures directly owned 3,198 shares of Bruker common stock, reflecting a routine, non-open-market adjustment for taxes rather than an elective share sale.

Rhea-AI Summary

Bruker Corp director Hermann Fritz Requardt received an equity grant of 4,520 shares of Common Stock in the form of restricted stock units. The award was granted at a price of $0.00 per share on February 15, 2026 as compensation rather than an open-market purchase.

The RSUs will vest in one installment on February 15, 2027, at which time each unit will automatically convert into one share of Bruker Common Stock. Following this grant, Requardt holds 30,965 shares of Common Stock in direct ownership, aligning his interests more closely with shareholders.

Rhea-AI Summary

Bruker Corp executive Mark Munch reported option exercises and a share sale. On February 13, he exercised stock options for 2,000 shares, converting derivative securities into common stock at a price of $22.19 per share. He then sold 2,000 common shares at $36.94 per share in an open-market transaction pursuant to a Rule 10b5-1 trading plan.

Following these transactions, he directly owned 128,443 shares of Bruker common stock and held 14,000 stock options.

Rhea-AI Summary

BRUKER CORP director Bonnie H. Anderson reported an equity award of 4,520 shares of Common Stock. The award was made at a price of $0.00 per share as a grant or other acquisition. Following this award, she reports beneficial ownership of 17,847 Common Stock shares.

According to the filing, the grant is in the form of Restricted Stock Units that will vest in a single installment on February 15, 2027. On that vesting date, each RSU will automatically convert into an equal number of shares of Bruker common stock.